Earlipoint Evaluation News Today

EarliTech Diagnostics secured $21.5 million, Manifold emerged with $15 million, and Beanstalk Benefits launched out of Redesign Health with $7.5 million.

The earlier interventions begin for children with autism, the better the potential outcomes. A new device will help reduce the time families have to wait for a diagnosis.

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

The earlier interventions begin for children with autism, the better the potential outcomes. A new device will help reduce the time families have to wait for a diagnosis.

Researchers have developed an eye-tracking device to measure and compare how children look at the world.

Called the EarliPoint Evaluation, the tool has been authorized by the FDA for use with children between the ages of 16 and 30 months.

An innovative FDA-approved technology that measures children's eye movements while watching social interaction movies may speed up autism spectrum disorder diagnosis.

Autism is typically diagnosed in children when they are 4 or 5 years old, but a new tool could make earlier detection and intervention possible.

A revolutionary tool that monitors childrens eye movements while they watch a video of a social interaction between two children could hasten the diagnosis of autism spectrum condition, according...

Two recent studies suggest that a newly developed eye-tracking tool may revolutionize the diagnosis of autism in young children. Currently, families often face long wait times for a diagnosis, and even then, the diagnosis may not be definitive. However, this tool, called EarliPoint Evaluation, has been cleared by the US Food and Drug Administration to assist clinicians in diagnosing and assessing autism.